Literature DB >> 20717727

Survivin is released from cancer cells via exosomes.

Salma Khan1, Jessica M S Jutzy, Jonathan R Aspe, Dalmor W McGregor, Jonathan W Neidigh, Nathan R Wall.   

Abstract

Inhibitor of apoptosis (IAP) and Heat shock proteins (HSPs) provide assistance in protecting cells from stresses of hypoxia, imbalanced pH, and altered metabolic and redox states commonly found in the microenvironmental mixture of tumor and nontumor cells. HSPs are upregulated, cell-surface displayed and released extracellularly in some types of tumors, a finding that until now was not shared by members of the IAP family. The IAP Survivin has been implicated in apoptosis inhibition and the regulation of mitosis in cancer cells. Survivin exists in a number of subcellular locations such as the mitochondria, cytoplasm, nucleus, and most recently, the extracellular space. Our previous work showing that extracellular survivin was able to enhance cellular proliferation, survival and tumor cell invasion provides evidence that Survivin might be secreted via an unidentified exocytotic pathway. In the present study, we describe for the first time the exosome-release of Survivin to the extracellular space both basally and after proton irradiation-induced stress. To examine whether exosomes contributed to Survivin release from cancer cells, exosomes were purified from HeLa cervical carcinoma cells and exosome quantity and Survivin content were determined. We demonstrate that although proton irradiation does not influence the exosomal secretory rate, the Survivin content of exosomes isolated from HeLa cells treated with a sublethal dose of proton irradiation (3 Gy) is significantly higher than control. These data identify a novel secretory pathway by which Survivin can be actively released from cells in both the basal and stress-induced state.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20717727      PMCID: PMC3174681          DOI: 10.1007/s10495-010-0534-4

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  52 in total

1.  Coordinated histone modifications mediated by a CtBP co-repressor complex.

Authors:  Yujiang Shi; Jun-ichi Sawada; Guangchao Sui; El Bachir Affar; Johnathan R Whetstine; Fei Lan; Hidesato Ogawa; Margaret Po-Shan Luke; Yoshihiro Nakatani; Yang Shi
Journal:  Nature       Date:  2003-04-17       Impact factor: 49.962

2.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search.

Authors:  Andrew Keller; Alexey I Nesvizhskii; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2002-10-15       Impact factor: 6.986

Review 3.  The case for survivin as a regulator of microtubule dynamics and cell-death decisions.

Authors:  Dario C Altieri
Journal:  Curr Opin Cell Biol       Date:  2006-08-24       Impact factor: 8.382

Review 4.  Exosomes biological significance: A concise review.

Authors:  Rose M Johnstone
Journal:  Blood Cells Mol Dis       Date:  2006-02-17       Impact factor: 3.039

5.  Isolation and characterization of exosomes from cell culture supernatants and biological fluids.

Authors:  Clotilde Théry; Sebastian Amigorena; Graça Raposo; Aled Clayton
Journal:  Curr Protoc Cell Biol       Date:  2006-04

6.  Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometry.

Authors:  A Clayton; J Court; H Navabi; M Adams; M D Mason; J A Hobot; G R Newman; B Jasani
Journal:  J Immunol Methods       Date:  2001-01-01       Impact factor: 2.303

7.  Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.

Authors:  Robert Gastpar; Mathias Gehrmann; Maria A Bausero; Alexzander Asea; Catharina Gross; Josef A Schroeder; Gabriele Multhoff
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

8.  Production and characterization of clinical grade exosomes derived from dendritic cells.

Authors:  Henry G Lamparski; Anita Metha-Damani; Jenq-Yuan Yao; Sanjay Patel; Di-Hwei Hsu; Curtis Ruegg; Jean-Bernard Le Pecq
Journal:  J Immunol Methods       Date:  2002-12-15       Impact factor: 2.303

9.  Rational design of shepherdin, a novel anticancer agent.

Authors:  Janet Plescia; Whitney Salz; Fang Xia; Marzia Pennati; Nadia Zaffaroni; Maria Grazia Daidone; Massimiliano Meli; Takehiko Dohi; Paola Fortugno; Yulia Nefedova; Dmitry I Gabrilovich; Giorgio Colombo; Dario C Altieri
Journal:  Cancer Cell       Date:  2005-05       Impact factor: 31.743

Review 10.  Prospects for exosomes in immunotherapy of cancer.

Authors:  G Mignot; S Roux; Clotilde Thery; Elodie Ségura; L Zitvogel
Journal:  J Cell Mol Med       Date:  2006 Apr-Jun       Impact factor: 5.310

View more
  99 in total

Review 1.  The biological significance and clinical applications of exosomes in ovarian cancer.

Authors:  Kalpana Deepa Priya Dorayappan; John J Wallbillich; David E Cohn; Karuppaiyah Selvendiran
Journal:  Gynecol Oncol       Date:  2016-04-10       Impact factor: 5.482

Review 2.  The emerging role of exosomes in survivin secretion.

Authors:  Salma Khan; Heather Ferguson Bennit; Nathan R Wall
Journal:  Histol Histopathol       Date:  2014-07-14       Impact factor: 2.303

Review 3.  Survivin at a glance.

Authors:  Sally P Wheatley; Dario C Altieri
Journal:  J Cell Sci       Date:  2019-04-04       Impact factor: 5.285

Review 4.  Pathogenic role of exosomes and microRNAs in HPV-mediated inflammation and cervical cancer: A review.

Authors:  Javid Sadri Nahand; Mohsen Moghoofei; Arash Salmaninejad; Zahra Bahmanpour; Mohammad Karimzadeh; Mitra Nasiri; Hamid Reza Mirzaei; Mohammad Hossein Pourhanifeh; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Int J Cancer       Date:  2019-10-31       Impact factor: 7.396

Review 5.  Tumor-Derived Exosomes and Their Role in Cancer Progression.

Authors:  Theresa L Whiteside
Journal:  Adv Clin Chem       Date:  2016-04-07       Impact factor: 5.394

6.  Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo.

Authors:  Robert A Fenstermaker; Sheila A Figel; Jingxin Qiu; Tara A Barone; Sanam S Dharma; Evan K Winograd; Phillip M Galbo; Laura M Wiltsie; Michael J Ciesielski
Journal:  Clin Cancer Res       Date:  2018-03-14       Impact factor: 12.531

7.  BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression.

Authors:  Aldo M Roccaro; Antonio Sacco; Patricia Maiso; Abdel Kareem Azab; Yu-Tzu Tai; Michaela Reagan; Feda Azab; Ludmila M Flores; Federico Campigotto; Edie Weller; Kenneth C Anderson; David T Scadden; Irene M Ghobrial
Journal:  J Clin Invest       Date:  2013-04       Impact factor: 14.808

8.  The Presence of Survivin on B Cells from Myasthenia Gravis Patients and the Potential of an Antibody to a Modified Survivin Peptide to Alleviate Weakness in an Animal Model.

Authors:  Xiangyang Zhang; Michael Ciesielski; Robert A Fenstermaker; Henry J Kaminski; Linda L Kusner
Journal:  J Immunol       Date:  2020-08-24       Impact factor: 5.422

Review 9.  Cell-to-cell miRNA transfer: from body homeostasis to therapy.

Authors:  Roxana S Redis; Steliana Calin; Yaling Yang; M James You; George A Calin
Journal:  Pharmacol Ther       Date:  2012-08-08       Impact factor: 12.310

10.  Microvesicle Cargo and Function Changes upon Induction of Cellular Transformation.

Authors:  Bridget T Kreger; Andrew L Dougherty; Kai Su Greene; Richard A Cerione; Marc A Antonyak
Journal:  J Biol Chem       Date:  2016-07-20       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.